Amelioration of chemotherapy induced cardiotoxicity:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Philadelphia, PA
Saunders
1998
|
Schriftenreihe: | Seminars in oncology
25,4, Suppl. 10 |
Schlagworte: | |
Beschreibung: | 99 S. zahlr. graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV012240059 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 981103s1998 d||| |||| 00||| eng d | ||
035 | |a (OCoLC)40104532 | ||
035 | |a (DE-599)BVBBV012240059 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 | ||
050 | 0 | |a RC271.C5 | |
245 | 1 | 0 | |a Amelioration of chemotherapy induced cardiotoxicity |c [James Speyer guest ed.] |
264 | 1 | |a Philadelphia, PA |b Saunders |c 1998 | |
300 | |a 99 S. |b zahlr. graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Seminars in oncology |v 25,4, Suppl. 10 | |
650 | 4 | |a Antineoplastic Agents |x toxicity | |
650 | 4 | |a Myocardial Diseases |x chemically induced | |
650 | 4 | |a Razoxane |x therapeutic use | |
700 | 1 | |a Speyer, James |d 1861-1941 |e Sonstige |0 (DE-588)117649465 |4 oth | |
999 | |a oai:aleph.bib-bvb.de:BVB01-008294131 |
Datensatz im Suchindex
_version_ | 1804126857077981184 |
---|---|
any_adam_object | |
author_GND | (DE-588)117649465 |
building | Verbundindex |
bvnumber | BV012240059 |
callnumber-first | R - Medicine |
callnumber-label | RC271 |
callnumber-raw | RC271.C5 |
callnumber-search | RC271.C5 |
callnumber-sort | RC 3271 C5 |
callnumber-subject | RC - Internal Medicine |
ctrlnum | (OCoLC)40104532 (DE-599)BVBBV012240059 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00945nam a2200301 cb4500</leader><controlfield tag="001">BV012240059</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">981103s1998 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)40104532</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012240059</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Amelioration of chemotherapy induced cardiotoxicity</subfield><subfield code="c">[James Speyer guest ed.]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia, PA</subfield><subfield code="b">Saunders</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">99 S.</subfield><subfield code="b">zahlr. graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Seminars in oncology</subfield><subfield code="v">25,4, Suppl. 10</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">toxicity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myocardial Diseases</subfield><subfield code="x">chemically induced</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Razoxane</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Speyer, James</subfield><subfield code="d">1861-1941</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)117649465</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008294131</subfield></datafield></record></collection> |
id | DE-604.BV012240059 |
illustrated | Illustrated |
indexdate | 2024-07-09T18:24:07Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008294131 |
oclc_num | 40104532 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | 99 S. zahlr. graph. Darst. |
publishDate | 1998 |
publishDateSearch | 1998 |
publishDateSort | 1998 |
publisher | Saunders |
record_format | marc |
series2 | Seminars in oncology |
spelling | Amelioration of chemotherapy induced cardiotoxicity [James Speyer guest ed.] Philadelphia, PA Saunders 1998 99 S. zahlr. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Seminars in oncology 25,4, Suppl. 10 Antineoplastic Agents toxicity Myocardial Diseases chemically induced Razoxane therapeutic use Speyer, James 1861-1941 Sonstige (DE-588)117649465 oth |
spellingShingle | Amelioration of chemotherapy induced cardiotoxicity Antineoplastic Agents toxicity Myocardial Diseases chemically induced Razoxane therapeutic use |
title | Amelioration of chemotherapy induced cardiotoxicity |
title_auth | Amelioration of chemotherapy induced cardiotoxicity |
title_exact_search | Amelioration of chemotherapy induced cardiotoxicity |
title_full | Amelioration of chemotherapy induced cardiotoxicity [James Speyer guest ed.] |
title_fullStr | Amelioration of chemotherapy induced cardiotoxicity [James Speyer guest ed.] |
title_full_unstemmed | Amelioration of chemotherapy induced cardiotoxicity [James Speyer guest ed.] |
title_short | Amelioration of chemotherapy induced cardiotoxicity |
title_sort | amelioration of chemotherapy induced cardiotoxicity |
topic | Antineoplastic Agents toxicity Myocardial Diseases chemically induced Razoxane therapeutic use |
topic_facet | Antineoplastic Agents toxicity Myocardial Diseases chemically induced Razoxane therapeutic use |
work_keys_str_mv | AT speyerjames ameliorationofchemotherapyinducedcardiotoxicity |